Severe hypophosphatemia in a 79-year-old man.
نویسندگان
چکیده
A 79-year-old white man with a history of progressive bone pain was admitted for evaluation 3 years ago. The patient reported that the pain began in both feet and gradually spread to the rest of the body over a 2-year period. Further assessment revealed multiple stress fractures in the feet. Bone mineral density test indicated osteopenia. Serial bone mineral density tests during the 2 years showed that his osteopenia was progressing. Results of several serum protein electrophoreses were essentially normal. His medical history, which included surgical removal of a cerebral aneurysm near the sella turcica and bacterial meningitis, suggested no pertinent etiologic factors. Physical examination revealed no clinically significant findings except unsteady gait. His serum phosphate concentrations declined from 2.5 to 1.8 mg/dL over the 2 years before admission. Laboratory test results at the time of admission are summarized in Table 1. The patient’s phosphate concentration reached a nadir of 1.2 mg/dL at admission. His serum alkaline phosphatase was increased. Other notable abnormalities included low normal calcium, normal to borderline high parathyroid hormone (PTH), 2 and increased 24-h urine phosphate and calcium excretion. Other routine biochemical parameters [including ionized calcium, thyroid-stimulating hormone, and free thyroxine (T4)] were normal. The patient underwent a whole-body scan showing multiple bone lesions. Diagnostic imaging studies including x-ray, a computer axial tomography (CAT), and MRI of the lungs, abdomen, and pelvis were reported to be normal at admission.
منابع مشابه
Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer
In a 68-year-old man on maintenance hemodialysis (HD), severe anemia was detected. Bone marrow biopsy was performed for investigation of pancytopenia and pathological examination revealed adenocarcinoma of the prostate. Prostate specific antigen (PSA) was 574 ng/mL. After androgen deprivation therapy was initiated, PSA decreased to 13.7 ng/mL. But subsequent elevation of PSA and pain due to bon...
متن کاملLow plasma glucose with normal finger-stick glucose.
A 63-year-old man with metastatic lung cancer admitted for severe hip pain and malaise was noted to have erratic daily morning plasma glucose concentrations, with several critical values below 40 mg/dL ( 2.2 mmol/L). Each time he had a critically low laboratory glucose value, a point-of-care finger-stick glucose was found to be within reference intervals. The remaining chemistry results were no...
متن کاملOsteopetrosis, Hypophosphatemia, and Phosphaturia in a Young Man: A Case Presentation and Differential Diagnosis
We report the case of a 30-year-old African-American male with osteopetrosis and hypophosphatemia, presenting with diffuse myalgias. Laboratory evaluation performed revealed a low serum phosphorus level with urinary phosphate wasting, low calcium, and 25-hydroxyvitamin D concentrations, as well as elevated alkaline phosphatase. Skull and pelvic radiographs revealed high bone density consistent ...
متن کاملSevere hypophosphatemia in a patient with diabetic ketoacidosis and acute respiratory failure.
Although hypophosphatemia is a common complication during therapy of diabetic ketoacidosis, it is seldom severe and rarely causes clinical manifestations. We report a 39-year-old woman with diabetic ketoacidosis who developed acute respiratory failure after therapy. Although hyperglycemia and acidosis were corrected after treatment, respiratory distress and weakness still persisted. The chest r...
متن کاملLong-Term Clinical Outcome and Carrier Phenotype in Autosomal Recessive Hypophosphatemia Caused by a Novel DMP1 Mutation
Homozygous inactivating mutations in DMP1 (dentin matrix protein 1), the gene encoding a noncollagenous bone matrix protein expressed in osteoblasts and osteocytes, cause autosomal recessive hypophosphatemia (ARHP). Herein we describe a family with ARHP owing to a novel homozygous DMP1 mutation and provide a detailed description of the associated skeletal dysplasia and carrier phenotype. The tw...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical chemistry
دوره 60 7 شماره
صفحات -
تاریخ انتشار 2014